NO149846C - Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2-substituerte-4-(4-(2-metyl-3-hydroksy-4-hydroksymetyl-5-pyridylmetyl)-1-piperazinyl)-6-metylpyrimidiner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2-substituerte-4-(4-(2-metyl-3-hydroksy-4-hydroksymetyl-5-pyridylmetyl)-1-piperazinyl)-6-metylpyrimidiner

Info

Publication number
NO149846C
NO149846C NO782408A NO782408A NO149846C NO 149846 C NO149846 C NO 149846C NO 782408 A NO782408 A NO 782408A NO 782408 A NO782408 A NO 782408A NO 149846 C NO149846 C NO 149846C
Authority
NO
Norway
Prior art keywords
methyl
myl
pyridylmethyl
piperazinyl
hydroxymethyl
Prior art date
Application number
NO782408A
Other languages
English (en)
Other versions
NO149846B (no
NO782408L (no
Inventor
Alain Beguin
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO782408L publication Critical patent/NO782408L/no
Publication of NO149846B publication Critical patent/NO149846B/no
Publication of NO149846C publication Critical patent/NO149846C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO782408A 1977-07-12 1978-07-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2-substituerte-4-(4-(2-metyl-3-hydroksy-4-hydroksymetyl-5-pyridylmetyl)-1-piperazinyl)-6-metylpyrimidiner NO149846C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2928177 1977-07-12

Publications (3)

Publication Number Publication Date
NO782408L NO782408L (no) 1979-01-15
NO149846B NO149846B (no) 1984-03-26
NO149846C true NO149846C (no) 1984-07-04

Family

ID=10289056

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782408A NO149846C (no) 1977-07-12 1978-07-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2-substituerte-4-(4-(2-metyl-3-hydroksy-4-hydroksymetyl-5-pyridylmetyl)-1-piperazinyl)-6-metylpyrimidiner

Country Status (28)

Country Link
US (1) US4174395A (no)
JP (1) JPS5452088A (no)
AR (1) AR218072A1 (no)
AT (1) AT358198B (no)
AU (1) AU517046B2 (no)
BE (1) BE868539A (no)
CA (1) CA1097645A (no)
CH (1) CH632267A5 (no)
DE (1) DE2830670C2 (no)
DK (1) DK148685C (no)
EG (1) EG13550A (no)
ES (1) ES471608A1 (no)
FI (1) FI63026C (no)
FR (2) FR2397413A1 (no)
HK (1) HK18783A (no)
IE (1) IE47027B1 (no)
IN (1) IN148661B (no)
LU (1) LU79916A1 (no)
MX (1) MX5103E (no)
MY (1) MY8500031A (no)
NL (1) NL170855C (no)
NO (1) NO149846C (no)
NZ (1) NZ187655A (no)
OA (1) OA06120A (no)
PT (1) PT68268A (no)
SE (1) SE436875B (no)
SG (1) SG60982G (no)
ZA (1) ZA783521B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387221B (de) * 1980-09-08 1988-12-27 Bristol Myers Co Verfahren zur herstellung des neuen
US6854146B2 (en) 2000-06-12 2005-02-15 Milliken & Company Method for producing digitally designed carpet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2459367A (en) * 1947-11-12 1949-01-18 American Cyanamid Co 1,4-di (heterocyclic substituted) piperazines
US2606906A (en) * 1948-10-14 1952-08-12 American Cyanamid Co 1-(2-pyridyl) piperazine and process of preparing same
US2748125A (en) * 1954-04-26 1956-05-29 American Cyanamid Co 1-substituted-4-sulfamylpiperazine and method of preparing the same
GB1433222A (no) * 1973-03-28 1976-04-22 Prod Ch8Mi Soc Et

Also Published As

Publication number Publication date
LU79916A1 (no) 1978-12-07
BE868539A (fr) 1978-10-16
DK148685C (da) 1986-02-17
HK18783A (en) 1983-06-10
SE7807721L (sv) 1979-01-13
CA1097645A (en) 1981-03-17
FR2397413B1 (no) 1980-07-18
DE2830670A1 (de) 1979-01-18
FI63026C (fi) 1983-04-11
JPS5452088A (en) 1979-04-24
NL7807228A (nl) 1979-01-16
AU517046B2 (en) 1981-07-02
IE781383L (en) 1979-01-12
SG60982G (en) 1983-09-02
AR218072A1 (es) 1980-05-15
FR2400362A1 (fr) 1979-03-16
ATA474578A (de) 1980-01-15
ES471608A1 (es) 1979-01-16
IE47027B1 (en) 1983-11-30
MX5103E (es) 1983-03-16
FI781982A (fi) 1979-01-13
FR2400362B1 (no) 1980-06-06
DK148685B (da) 1985-09-02
FI63026B (fi) 1982-12-31
IN148661B (no) 1981-05-02
NZ187655A (en) 1980-10-24
DK310678A (da) 1979-01-13
AT358198B (de) 1980-08-25
AU3793478A (en) 1980-01-17
ZA783521B (en) 1979-06-27
NO149846B (no) 1984-03-26
CH632267A5 (fr) 1982-09-30
EG13550A (en) 1982-03-31
NL170855B (nl) 1982-08-02
PT68268A (en) 1978-08-01
FR2397413A1 (fr) 1979-02-09
DE2830670C2 (de) 1983-01-20
JPS5725554B2 (no) 1982-05-29
US4174395A (en) 1979-11-13
OA06120A (fr) 1981-06-30
SE436875B (sv) 1985-01-28
NO782408L (no) 1979-01-15
NL170855C (nl) 1983-01-03
MY8500031A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO152972C (no) Analogifremgangsmaate for fremstilling av 2-(1-fenylbenzimidazolyl)-acetohydroksamsyre med terapeutisk aktivitet.
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO146392C (no) Analogifremgangsmaate ved fremstilling av nye analgesisk aktive n-acetyl-para-aminofenyl-n`-acetyl-aminoalkansyreester-derivater
NO154426C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO153055C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 2-(2-pyridyl)tetrahydrotiofen
NO146710C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylpiperazinderivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO147749C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropaner